Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan - PubMed (original) (raw)
Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan
G Pluschke et al. Proc Natl Acad Sci U S A. 1996.
Abstract
A human melanoma-associated chondroitin sulfate proteoglycan (MCSP), recognized by mAb 9.2.27, plays a role in stabilizing cell-substratum interactions during early events of melanoma cell spreading on endothelial basement membranes. We report here the molecular cloning and nucleotide sequencing of cDNA encoding the entire core protein of human MCSP and provide its deduced amino acid sequence. This core protein contains an open reading frame of 2322 aa, encompassing a large extracellular domain, a hydrophobic transmembrane region, and a relatively short cytoplasmic tail. Northern blot analysis indicated that MCSP cDNA probes detect a single 8.0-kb RNA species expressed in human melanoma cell lines. In situ hybridization experiments with a segment of the MCSP coding sequence localized MCSP mRNA in biopsies prepared from melanoma skin metastases. Multiple human Northern blots with an MCSP-specific probe revealed a strong hybridization signal only with melanoma cells and not with other human cancer cells or a variety of human fetal and adult tissues. These data indicate that MCSP represents an integral membrane chondroitin sulfate proteoglycan expressed by human malignant melanoma cells. The availability of cDNAs encoding MCSP should facilitate studies designed to establish correlations between structure and function of this molecule and help to establish its role in the progression of human malignant melanoma.
Similar articles
- Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain.
Rauch U, Karthikeyan L, Maurel P, Margolis RU, Margolis RK. Rauch U, et al. J Biol Chem. 1992 Sep 25;267(27):19536-47. J Biol Chem. 1992. PMID: 1326557 - Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms.
Yang J, Price MA, Neudauer CL, Wilson C, Ferrone S, Xia H, Iida J, Simpson MA, McCarthy JB. Yang J, et al. J Cell Biol. 2004 Jun 21;165(6):881-91. doi: 10.1083/jcb.200403174. J Cell Biol. 2004. PMID: 15210734 Free PMC article. - Phosphacan, a chondroitin sulfate proteoglycan of brain that interacts with neurons and neural cell-adhesion molecules, is an extracellular variant of a receptor-type protein tyrosine phosphatase.
Maurel P, Rauch U, Flad M, Margolis RK, Margolis RU. Maurel P, et al. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2512-6. doi: 10.1073/pnas.91.7.2512. Proc Natl Acad Sci U S A. 1994. PMID: 7511813 Free PMC article. - Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance.
Campoli MR, Chang CC, Kageshita T, Wang X, McCarthy JB, Ferrone S. Campoli MR, et al. Crit Rev Immunol. 2004;24(4):267-96. doi: 10.1615/critrevimmunol.v24.i4.40. Crit Rev Immunol. 2004. PMID: 15588226 Review. - Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality.
Tamburini E, Dallatomasina A, Quartararo J, Cortelazzi B, Mangieri D, Lazzaretti M, Perris R. Tamburini E, et al. FASEB J. 2019 Mar;33(3):3112-3128. doi: 10.1096/fj.201801670R. Epub 2018 Dec 14. FASEB J. 2019. PMID: 30550356 Review.
Cited by
- C-type lectin-like domains in Fugu rubripes.
Zelensky AN, Gready JE. Zelensky AN, et al. BMC Genomics. 2004 Aug 1;5(1):51. doi: 10.1186/1471-2164-5-51. BMC Genomics. 2004. PMID: 15285787 Free PMC article. - Antithetic roles of proteoglycans in cancer.
Garusi E, Rossi S, Perris R. Garusi E, et al. Cell Mol Life Sci. 2012 Feb;69(4):553-79. doi: 10.1007/s00018-011-0816-1. Epub 2011 Oct 2. Cell Mol Life Sci. 2012. PMID: 21964924 Free PMC article. Review. - Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for Clostridium difficile toxin B.
Yuan P, Zhang H, Cai C, Zhu S, Zhou Y, Yang X, He R, Li C, Guo S, Li S, Huang T, Perez-Cordon G, Feng H, Wei W. Yuan P, et al. Cell Res. 2015 Feb;25(2):157-68. doi: 10.1038/cr.2014.169. Epub 2014 Dec 30. Cell Res. 2015. PMID: 25547119 Free PMC article. - Theranostic impact of NG2/CSPG4 proteoglycan in cancer.
Nicolosi PA, Dallatomasina A, Perris R. Nicolosi PA, et al. Theranostics. 2015 Feb 15;5(5):530-44. doi: 10.7150/thno.10824. eCollection 2015. Theranostics. 2015. PMID: 25767619 Free PMC article. Review. - Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma.
Chen K, Yong J, Zauner R, Wally V, Whitelock J, Sajinovic M, Kopecki Z, Liang K, Scott KF, Mellick AS. Chen K, et al. Cancers (Basel). 2022 Nov 13;14(22):5564. doi: 10.3390/cancers14225564. Cancers (Basel). 2022. PMID: 36428658 Free PMC article. Review.
References
- Hybridoma. 1982;1(4):423-32 - PubMed
- Hybridoma. 1982;1(3):283-92 - PubMed
- J Clin Oncol. 1984 Nov;2(11):1235-44 - PubMed
- Science. 1986 Mar 14;231(4743):1281-4 - PubMed
- J Immunol. 1974 May;112(5):1766-73 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous